On the upside
Shares of Angiotech Pharmaceuticals (Nasdaq: ANPI) continued rising after the FDA approved its TAXUS Liberte Atom Stent system yesterday.
CuraGen (NYSE: CRGN) will present data at the American Society of Clinical Oncology meeting this weekend from three clinical trials of its anti-body drug conjugate CR011-vcMMAE.
Cytori (Nasdaq: CYTX) published its first preclinical study showing significant improvement in the cardiac function of heart attack patients after treatment with adipose-derived stem and regenerative cells.
On the downside
Sealy (NYSE: ZZ) will launch a rights offering.
Revlon (NYSE: REV) announced the elimination of 400 jobs and warned that second quarter results will be weak.
In the broad market, advancing issues outpaced decliners by a margin of nearly 2 to 1 on the NYSE and by nearly 9 to 7 on Nasdaq. The Russell 2000 which tracks small cap stocks added 2 points to 492.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here